# Lovelace Biomedical Research Institute – FDA Inspection, Sep 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/lovelace-biomedical-research-institute/765a21f2-b44c-4977-81fd-b38380d4a9af
Source feed: FDA_Inspections

> FDA inspection 1101842 of Lovelace Biomedical Research Institute, September 13, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 58. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101842
- Company Name: Lovelace Biomedical Research Institute
- Inspection Date: 2019-09-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1267403 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/lovelace-biomedical-research-institute/1ee66b6b-459f-4d9c-bd1a-5c24c9233631)
- FDA Inspection 1220523 - 2023-09-14
- FDA Inspection 1118971 - 2020-01-31
- [FDA Inspection 998362 - 2016-11-11](https://www.keypedia.com/records/fda_inspections/lovelace-biomedical-research-institute/f6e21a15-ef32-47e1-b2ee-a293b86c8be1)

## Related Officers

- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/jeanne-j-thai/f7b057a4-ab4c-43de-a448-384ff9f8598f)
- [Company Rep](https://www.keypedia.com/people/ruth-a-williams/f6dd5e30-fe9a-4b18-9703-dc471a55f24f)
- [Company Rep](https://www.keypedia.com/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)

Company: https://www.keypedia.com/companies/lovelace-biomedical-research-institute/3d1ce1c8-86cd-403c-b468-d2b26ef4c77c

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face